BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31118812)

  • 1. A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients.
    Yang LP; Wang ZX; He MM; Wu HX; Yuan SQ; Wang W; Jin Y; Ren C; Wang ZQ; Wang FH; Li YH; Wang F; Xu RH
    Cancer Manag Res; 2019; 11():3993-4003. PubMed ID: 31118812
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis.
    Yuan SQ; Nie RC; Chen S; Chen XJ; Chen YM; Xu LP; Yang LF; Zhou ZW; Peng JS; Chen YB
    J Cancer; 2017; 8(12):2231-2237. PubMed ID: 28819425
    [No Abstract]   [Full Text] [Related]  

  • 3. The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching.
    Yang LP; Wang ZX; He MM; Jin Y; Ren C; Wang ZQ; Wang FH; Li YH; Wang F; Xu RH
    J Cancer; 2019; 10(3):602-610. PubMed ID: 30719157
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
    Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefits of palliative gastrectomy in stage IV gastric cancer: a propensity score matched analysis.
    Peng W; Ma T; Xu H; Wu Z; Wu C; Sun G
    J Gastrointest Oncol; 2020 Apr; 11(2):376-385. PubMed ID: 32399278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis.
    Nie RC; Chen S; Yuan SQ; Chen XJ; Chen YM; Zhu BY; Qiu HB; Peng JS; Chen YB
    Ann Surg Oncol; 2016 Nov; 23(12):3956-3963. PubMed ID: 27380641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of palliative gastrectomy in incurable advanced gastric cancer: a retrospective cohort study and meta-analysis.
    Zheng C; Gao ZM; Huang HB; Li K; Liu XF
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2299-2312. PubMed ID: 33755967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative Gastrectomy Improves the Survival of Patients with Metastatic Early-Onset Gastric Cancer: A Retrospective Cohort Study.
    An H; Wang PY; Liu YC
    Curr Oncol; 2023 Aug; 30(9):7874-7890. PubMed ID: 37754487
    [No Abstract]   [Full Text] [Related]  

  • 9. Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis.
    Wu P; Wang P; Ma B; Yin S; Tan Y; Hou W; Wang Z; Xu H; Zhu Z
    Cancer Manag Res; 2018; 10():4759-4771. PubMed ID: 30464590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of palliative gastrectomy for late-stage gastric cancer patients.
    Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
    J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
    Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
    World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study.
    Li W; Jiang H; Yu Y; Wang Y; Wang Z; Cui Y; Shen K; Shen Z; Fang Y; Liu T
    Cancer Manag Res; 2019; 11():2007-2013. PubMed ID: 30881125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination.
    Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng J
    World J Surg Oncol; 2017 Feb; 15(1):52. PubMed ID: 28228146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study.
    Liao PW; Cheng SB; Chou CW; Lin HC; Lin CH; Chen TC; Hsu CY; Jerry Teng CL; Shih YH
    Clin Med Insights Oncol; 2022; 16():11795549221123617. PubMed ID: 36134036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrectomy for Metastatic Gastric Cancer: a 15-year Experience from a Developing Country.
    Sahakyan MА; Gabrielyan A; Aghayan DL; Yesayan S; Petrosyan H; Chobanyan А; Kazaryan AM; Sahakyan AM
    Indian J Surg Oncol; 2019 Sep; 10(3):527-534. PubMed ID: 31496605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
    Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
    Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.